• Correction doses can be used to manage hyperglycemia, with dosing iniated at 0.5–1 U of rapid‐acting insulin per 50 mg/dL increase in glucose levels above 150 mg/dL, adjusted according to glucose monitoring. The gene discussed is INS; the disease is Hyperglycemia.